To the full analysis
Agilysys stock: growth
AGYSAgilysys reported $319.31M in revenue for fiscal 2026, up 15.8% on the prior year, up 18.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−2.1%
per year from 2007 to 2026, per share −1.6%
Earnings (Annual rate)
−9%
per year from 2007 to 2026, per share −8.5%
Free cash flow (Annual rate)
4%
per year from 2007 to 2026, per share 4.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 18.4% | 10.2% | −2.1% |
| Revenue per share | 14.3% | 7.8% | −1.6% |
| Earnings | no data | no data | −9.0% |
| Earnings per share | no data | no data | −8.5% |
| Free cash flow | 20.3% | no data | 4.0% |
| Free cash flow per share | 16.1% | no data | 4.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $474.57M | $232.86M | $32.31M |
| 2008 | $770.96M | $3.66M | −$166.12M |
| 2009 | $730.72M | −$284.13M | −$93.04M |
| 2010 | $640.43M | $3.55M | $90.62M |
| 2011 | $675.47M | −$55.48M | $7.79M |
| 2012 | $208.89M | −$22.78M | −$26.62M |
| 2013 | $236.14M | −$1.3M | −$18M |
| 2014 | $101.26M | $17.1M | −$16.15M |
| 2015 | $103.51M | −$11.5M | −$22.65M |
| 2016 | $120.37M | −$3.77M | −$13.73M |
| 2017 | $127.68M | −$11.72M | −$12.61M |
| 2018 | $127.36M | −$8.35M | −$8.18M |
| 2019 | $140.84M | −$13.16M | $1.73M |
| 2020 | $160.76M | −$34.07M | $7.16M |
| 2021 | $137.18M | −$21M | $27.02M |
| 2022 | $162.64M | $6.48M | $27.28M |
| 2023 | $198.07M | $14.58M | $27.23M |
| 2024 | $237.46M | $86.2M | $40.06M |
| 2025 | $275.62M | $23.23M | $52.35M |
| 2026 | $319.31M | $38.79M | $68.15M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Mar 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.